Andressa Vollono Barbosa

Mrs. Andressa Vollono Barbosa


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 February 2024 in Biology
Verified
Journal Article
Open access
PDF file
LRLeonardo Siquara da Rocha
Leonardo Siquara da Rocha
Everton Freitas de MoraisEverton Freitas de Morais
Everton Freitas de Morais
Lilianny Querino Rocha de OliveiraLilianny Querino Rocha de Oliveira
Lilianny Querino Rocha de Oliveira
ABAndressa Vollono Barbosa
Andressa Vollono Barbosa
DLDaniel Lambert
Daniel Lambert
Ricardo D. ColettaRicardo D. Coletta
Ricardo D. Coletta
Oral squamous cell carcinoma (OSCC) is the most common and lethal type of head and neck cancer in the world. Variable response and acquisition of resistance to traditional therapies show that it is essential to develop novel strategies that can provide better outcomes for the patient. Understanding of cellular and molecular mechanisms of cell death control has increased rapidly in recent years. Activation of cell death pathways, such as the emerging forms of non-apoptotic programmed cell death, including ferroptosis, pyroptosis, necroptosis, NETosis, parthanatos, mitoptosis and paraptosis, may represent clinically relevant novel therapeutic opportunities. This systematic review summarizes the recently described forms of cell death in OSCC, highlighting their potential for informing diagnosis, prognosis and treatment. Original studies that explored any of the selected cell deaths in OSCC were included. Electronic search, study selection, data collection and risk of bias assessment tools were realized. The literature search was carried out in four databases, and the extracted data from 79 articles were categorized and grouped by type of cell death. Ferroptosis, pyroptosis, and necroptosis represented the main forms of cell death in the selected studies, with links to cancer immunity and inflammatory responses, progression and prognosis of OSCC. Harnessing the potential of these pathways may be useful in patient-specific prognosis and individualized therapy. We provide perspectives on how these different cell death types can be integrated to develop decision tools for diagnosis, prognosis, and treatment of OSCC.

25 February 2025 in Lasers in Medical Science
Verified
Journal Article
Open access
PDF file
AJAnildo Alves de Brito Júnior
Anildo Alves de Brito Júnior
PCPedro J. L. Crugeira
Pedro J. L. Crugeira
ABAndressa Vollono Barbosa
Andressa Vollono Barbosa
WCWellington Luis Reis Costa
Wellington Luis Reis Costa
MCMaria Cristina Teixeira Cangussu
Maria Cristina Teixeira Cangussu
JAJuliana Monteiro Azevedo
Juliana Monteiro Azevedo
The efficiency of antibiotics in terms of their bacterial inhibition is well known. However, studies show that its overuse, underuse, and misuse induce antimicrobial resistance, promoting the need to work with alternative methods. In this sense, antimicrobial photodynamic therapy (aPDT) is a promising selective method demonstrating excellent response. This study aimed to evaluate the antimicrobial action promoted in Staphylococcus aureus using 1,9 dimethyl methylene blue dye (DMMB) combined with red LED (λ 630 ± 20 nm, CW, 125 mW, 12 J/ cm², 192 s) in planktonic culture and rats skin wounds contaminated with staphylococcal bacteria. The experimental in vitro and in vivo groups were Control, LED, DMMB, and LED + DMMB; after aPDT, the triplicate samples for each dilution were incubated for 24 h, and the number of bacteria was determined by counting the colony-forming units, and the logarithm (CFU/mL log). Based on in vitro data obtained, the LED + DMMB group, when compared to the Control, showed a reduction in microbial load of 99.943% ( p < 0.0001), with decimal reduction (RD = 3). Whereas in vivo results, the same comparing groups demonstrated a reduction in microbial load, reaching 99.994% (RD = 4). In this research, the aPDT was a unique treatment, and it is possible to repeat it to obtain higher microbial reduction, providing an alternative therapeutic that can be clinically validated to combat infections caused by S. aureus .

19 February 2025 in Lasers in Medical Science
Verified
Journal Article
Closed access
PDF file
AJAnildo Alves de Brito Júnior
Anildo Alves de Brito Júnior
PCPedro J. L. Crugeira
Pedro J. L. Crugeira
WCWellington Luis Reis Costa
Wellington Luis Reis Costa
ABAndressa Vollono Barbosa
Andressa Vollono Barbosa
SOSusana Carla Pires Sampaio de Oliveira
Susana Carla Pires Sampaio de Oliveira
APAntonio Luiz Barbosa Pinheiro
Antonio Luiz Barbosa Pinheiro